The DOI matches its Crossref record; 237 of the 237 references it cites were found in a registry or an index.
The emerging role of TGF-β superfamily coreceptors in cancer
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
The Transforming Growth Factor-beta Family
Massague, J. (1990) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.06.110190.003121 · Cited by 3,015
TGF-β-induced epithelial to mesenchymal transition
Xu, J., Lamouille, S., & Derynck, R. (2009) · Cell Research · doi:10.1038/cr.2009.5 · Cited by 2,804
TGF-β signaling and the fibrotic response
Leask, A., & Abraham, D. J. (2004) · The FASEB Journal · doi:10.1096/fj.03-1273rev · Cited by 2,319
TGF-β Signaling in Tumor Suppression and Cancer Progression
Derynck, R., Akhurst, R. J., & Balmain, A. (2001) · Nature Genetics · doi:10.1038/ng1001-117 · Cited by 2,275
TRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSES
Li, M. O., Wan, Y. Y., Sanjabi, S., Robertson, A.-K. L., & Flavell, R. A. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090737 · Cited by 2,206
Bissell, M. J., & Radisky, D. (2001) · Nature Reviews Cancer · doi:10.1038/35094059 · Cited by 2,180
SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS
Feng, X.-H., & Derynck, R. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.022404.142018 · Cited by 1,869
Soluble endoglin contributes to the pathogenesis of preeclampsia
Venkatesha, S., Toporsian, M., Lam, C., Hanai, J.-I., Mammoto, T., Kim, Y. M., Bdolah, Y., Lim, K.-H., Yuan, H.-T., Libermann, T. A., et al. (2006) · Nature Medicine · doi:10.1038/nm1429 · Cited by 1,855 · cited 1×
“In addition, Sol-Eng is involved in the pathogenesis of severe vascular diseases, such as the pregnancy-specific hypertensive syndrome known as preeclampsia [72,165,166] and”
BackgroundWeidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. N., Moore, D. H., Meli, S., & Gasparini, G. (1992) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/84.24.1875 · Cited by 1,775
Epithelial–mesenchymal transitions in development and pathologies
Thiery, J. P. (2003) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2003.10.006 · Cited by 1,704
Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer
Siegel, P. M., & Massagué, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1208 · Cited by 1,604
McAllister, K. A., Grogg, K. M., Johnson, D. W., Gallione, C. J., Baldwin, M. A., Jackson, C. E., Helmbold, E. A., Markel, D. S., McKinnon, W. C., Murrel, J., et al. (1994) · Nature Genetics · doi:10.1038/ng1294-345 · Cited by 1,482
TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia
Bhowmick, N. A., Chytil, A., Plieth, D., Gorska, A. E., Dumont, N., Shappell, S., Washington, M. K., Neilson, E. G., & Moses, H. L. (2004) · Science · doi:10.1126/science.1090922 · Cited by 1,401
TGFβ: the molecular Jekyll and Hyde of cancer
Bierie, B., & Moses, H. L. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1926 · Cited by 1,267
Johnson, D. W., Berg, J. N., Baldwin, M. A., Gallione, C. J., Marondel, I., Yoon, S.-J., Stenzel, T. T., Speer, M., Pericak-Vance, M. A., Diamond, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0696-189 · Cited by 1,116
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression
Babitt, J. L., Huang, F. W., Wrighting, D. M., Xia, Y., Sidis, Y., Samad, T. A., Campagna, J. A., Chung, R. T., Schneyer, A. L., Woolf, C. J., et al. (2006) · Nature Genetics · doi:10.1038/ng1777 · Cited by 1,026
Klein, U., Tu, Y., Stolovitzky, G. A., Mattioli, M., Cattoretti, G., Husson, H., Freedman, A., Inghirami, G., Cro, L., Baldini, L., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.11.1625 · Cited by 918
Mutations in the SMAD4/DPC4 Gene in Juvenile Polyposis
Howe, J. R., Roth, S., Ringold, J. C., Summers, R. W., Järvinen, H. J., Sistonen, P., Tomlinson, I. P. M., Houlston, R. S., Bevan, S., Mitros, F. A., et al. (1998) · Science · doi:10.1126/science.280.5366.1086 · Cited by 907
Betaglycan presents ligand to the TGFβ signaling receptor
López-Casillas, F., Wrana, J. L., & Massagué, J. (1993) · Cell · doi:10.1016/0092-8674(93)90368-z · Cited by 901
α-lnhibin is a tumour-suppressor gene with gonadal specificity in mice
Matzuk, M. M., Finegold, M. J., Su, J.-G. J., Hsueh, A. J. W., & Bradley, A. (1992) · Nature · doi:10.1038/360313a0 · Cited by 890
Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis
Quintanilla, M., Brown, K., Ramsden, M., & Balmain, A. (1986) · Nature · doi:10.1038/322078a0 · Cited by 859
Self-citationDefective Angiogenesis in Mice Lacking Endoglin
Li, D. Y., Sorensen, L. K., Brooke, B. S., Urness, L. D., Davis, E. C., Taylor, D. G., Boak, B. B., & Wendel, D. P. (1999) · Science · doi:10.1126/science.284.5419.1534 · Cited by 852
Oh, S. P., Seki, T., Goss, K. A., Imamura, T., Yi, Y., Donahoe, P. K., Li, L., Miyazono, K., ten Dijke, P., Kim, S., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.6.2626 · Cited by 851
Cheifetz, S., Bellón, T., Calés, C., Vera, S., Bernabeu, C., Massagué, J., & Letarte, M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41732-2 · Cited by 836
Self-citationHorak, E. R., Klenk, N., Leek, R., LeJeune, S., Smith, K., Stuart, N., Harris, A. L., Greenall, M., & Stepniewska, K. (1992) · The Lancet · doi:10.1016/0140-6736(92)93150-l · Cited by 800
Extracellular control of TGFβ signalling in vascular development and disease
ten Dijke, P., & Arthur, H. M. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2262 · Cited by 778
Mishina, Y., Suzuki, A., Ueno, N., & Behringer, R. R. (1995) · Genes & Development · doi:10.1101/gad.9.24.3027 · Cited by 776
Gallione, C. J., Repetto, G. M., Legius, E., Rustgi, A. K., Schelley, S. L., Tejpar, S., Mitchell, G., Drouin, É., Westermann, C. J., & Marchuk, D. A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15732-2 · Cited by 756
Massagué, J., & Gomis, R. R. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.04.033 · Cited by 721
David, L., Mallet, C., Mazerbourg, S., Feige, J.-J., & Bailly, S. (2007) · Blood · doi:10.1182/blood-2006-07-034124 · Cited by 708
López-Casillas, F., Cheifetz, S., Doody, J., Andres, J. L., Lane, W. S., & Massague, J. (1991) · Cell · doi:10.1016/0092-8674(91)90073-8 · Cited by 676
Endoglin promotes endothelial cell proliferation and TGF‐β/ALK1 signal transduction
Lebrin, F., Goumans, M., Jonker, L., Carvalho, R. L., Valdimarsdottir, G., Thorikay, M., Mummery, C., Arthur, H. M., & Dijke, P. T. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600386 · Cited by 652
Role of transforming growth factor-β superfamily signaling pathways in human disease
Gordon, K. J., & Blobe, G. C. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.01.006 · Cited by 641
Expression cloning and characterization of the TGF-β type III receptor
Wang, X.-F., Lin, H. Y., Ng-Eaton, E., Downward, J., Lodish, H. F., & Weinberg, R. A. (1991) · Cell · doi:10.1016/0092-8674(91)90074-9 · Cited by 637
Mechanism of TGF-β signaling to growth arrest, apoptosis, and epithelial–mesenchymal transition
Heldin, C.-H., Landström, M., & Moustakas, A. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.01.021 · Cited by 634
Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis
Howe, J. R., Bair, J. L., Sayed, M. G., Anderson, M. E., Mitros, F. A., Petersen, G. M., Velculescu, V. E., Traverso, G., & Vogelstein, B. (2001) · Nature Genetics · doi:10.1038/88919 · Cited by 629
Cui, W., Fowlis, D. J., Bryson, S., Duffie, E., Ireland, H., Balmain, A., & Akhurst, R. J. (1996) · Cell · doi:10.1016/s0092-8674(00)80127-0 · Cited by 628
Betaglycan binds inhibin and can mediate functional antagonism of activin signalling
Lewis, K. A., Gray, P. C., Blount, A. L., MacConell, L. A., Wiater, E., Bilezikjian, L. M., & Vale, W. (2000) · Nature · doi:10.1038/35006129 · Cited by 583
Vascular Targeting Agents as Cancer Therapeutics
Thorpe, P. E. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0642-03 · Cited by 577
Barbara, N. P., Wrana, J. L., & Letarte, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.2.584 · Cited by 565
CD105 is important for angiogenesis: evidence and potential applications
DUFF, S. E., LI, C., GARLAND, J. M., & KUMAR, S. (2003) · The FASEB Journal · doi:10.1096/fj.02-0634rev · Cited by 556
Alterations in components of the TGF-β superfamily signaling pathways in human cancer
LEVY, L., & HILL, C. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.09.009 · Cited by 539
Scharpfenecker, M., van Dinther, M., Liu, Z., van Bezooijen, R. L., Zhao, Q., Pukac, L., Löwik, C. W. G. M., & ten Dijke, P. (2007) · Journal of Cell Science · doi:10.1242/jcs.002949 · Cited by 531
Actions of TGF-β as tumor suppressor and pro-metastatic factor in human cancer
Pardali, K., & Moustakas, A. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.06.004 · Cited by 526
TGF-β signaling in vascular fibrosis
RUIZORTEGA, M., RODRIGUEZVITA, J., SANCHEZLOPEZ, E., CARVAJAL, G., & EGIDO, J. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.02.008 · Cited by 492
Hereditary haemorrhagic telangiectasia: a clinical and scientific review
Govani, F. S., & Shovlin, C. L. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2009.35 · Cited by 491
A murine model of hereditary hemorrhagic telangiectasia
Bourdeau, A., Dumont, D. J., & Letarte, M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci8088 · Cited by 468
Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells.
Gougos, A., & Letarte, M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38892-1 · Cited by 452
Arthur, H. M., Ure, J., Smith, A. J. H., Renforth, G., Wilson, D. I., Torsney, E., Charlton, R., Parums, D. V., Jowett, T., Marchuk, D. A., et al. (2000) · Developmental Biology · doi:10.1006/dbio.1999.9534 · Cited by 436
Invadopodia: Specialized Cell Structures for Cancer Invasion
Weaver, A. M. (2006) · Clinical & Experimental Metastasis · doi:10.1007/s10585-006-9014-1 · Cited by 424
Nature and nurture – lessons from chemical carcinogenesis
Luch, A. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1546 · Cited by 421
Deletion of p16 and p15 genes in brain tumors.
Jen, J., Harper, J. W., Bigner, S. H., Bigner, D. D., Papadopoulos, N., Markowitz, S. D., Willson, J. K. V., Kinzler, K. W., & Vogelstein, B. (1994) · PubMed · Cited by 404
López-Casillas, F., Payne, H., Andres, J., & Massagué, J. (1994) · The Journal of cell biology · doi:10.1083/jcb.124.4.557 · Cited by 393
Requirement of Type III TGF-β Receptor for Endocardial Cell Transformation in the Heart
Brown, C. B., Boyer, A. S., Runyan, R. B., & Barnett, J. V. (1999) · Science · doi:10.1126/science.283.5410.2080 · Cited by 383
Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease
Abdalla, S. A., & Letarte, M. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2005.030833 · Cited by 381
‘Yin–Yang’ functions of transforming growth factor‐β and T regulatory cells in immune regulation
Wan, Y. Y., & Flavell, R. A. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00565.x · Cited by 380
Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis.
Kumar, S., Ghellal, A., Li, C., Byrne, G. J., Haboubi, N. Y., Wang, J. M., & Bundred, N. J. (1999) · PubMed · Cited by 361
Andres, J. L., Stanley, K., Cheifetz, S., & Massagué, J. (1989) · The Journal of cell biology · doi:10.1083/jcb.109.6.3137 · Cited by 354
Levy, L., & Hill, C. S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.18.8108-8125.2005 · Cited by 342
Burrows, F. J., Derbyshire, E. J., Tazzari, P. L., Amlot, P. L., Gazdar, A. F., King, S. W., Letarte, M., Vitetta, E. S., & Thorpe, P. E. (1995) · PubMed · Cited by 334
Endoglin in angiogenesis and vascular diseases
ten Dijke, P., Goumans, M.-J., & Pardali, E. (2008) · Angiogenesis · doi:10.1007/s10456-008-9101-9 · Cited by 327
Sánchez-Elsner, T., Botella, L. M., Velasco, B., Langa, C., & Bernabéu, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207160200 · Cited by 326
A large domain common to sperm receptors (Zp2 and Zp3) and TGF‐β type III receptor
Bork, P., & Sander, C. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80853-9 · Cited by 315
ZONA PELLUCIDA DOMAIN PROTEINS
Jovine, L., Darie, C. C., Litscher, E. S., & Wassarman, P. M. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133039 · Cited by 306
Endoglin modulates cellular responses to TGF-beta 1.
Lastres, P., Letamendía, A., Zhang, H., Rius, C., Almendro, N., Raab, U., López, L. A., Langa, C., Fabra, A., Letarte, M., et al. (1996) · The Journal of cell biology · doi:10.1083/jcb.133.5.1109 · Cited by 304
The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis
Yuspa, S. H. (1998) · Journal of Dermatological Science · doi:10.1016/s0923-1811(97)00071-6 · Cited by 300
The risk of gastrointestinal carcinoma in familial juvenile polyposis
Howe, J. R., Mitros, F. A., & Summers, R. W. (1998) · Annals of Surgical Oncology · doi:10.1007/bf02303487 · Cited by 297
Risk of colorectal cancer in juvenile polyposis
Brosens, L. A. A., van Hattem, A., Hylind, L. M., Iacobuzio-Donahue, C., Romans, K. E., Axilbund, J., Cruz-Correa, M., Tersmette, A. C., Offerhaus, G. J. A., & Giardiello, F. M. (2007) · Gut · doi:10.1136/gut.2006.116913 · Cited by 278
Tanaka, F., Otake, Y., Yanagihara, K., Kawano, Y., Miyahara, R., Li, M., Yamada, T., Hanaoka, N., Inui, K., & Wada, H. (2001) · PubMed · Cited by 274
Howe, J. R., Sayed, M. G., Ahmed, A. F., Ringold, J., Larsen-Haidle, J., Merg, A., Mitros, F. A., Vaccaro, C. A., Petersen, G. M., Giardiello, F. M., et al. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.018598 · Cited by 269
SMAD4 mutations found in unselected HHT patients
Gallione, C. J., Richards, J. A., Letteboer, T. G. W., Rushlow, D., Prigoda, N. L., Leedom, T. P., Ganguly, A., Castells, A., Ploos van Amstel, J. K., Westermann, C. J. J., et al. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2006.041517 · Cited by 258
ß-Arrestin 2 Mediates Endocytosis of Type III TGF-ß Receptor and Down-Regulation of Its Signaling
Chen, W., Kirkbride, K. C., How, T., Nelson, C. D., Mo, J., Frederick, J. P., Wang, X.-F., Lefkowitz, R. J., & Blobe, G. C. (2003) · Science · doi:10.1126/science.1083195 · Cited by 258
Yuspa, S. H. (1994) · PubMed · Cited by 255
Toporsian, M., Gros, R., Kabir, M. G., Vera, S., Govindaraju, K., Eidelman, D. H., Husain, M., & Letarte, M. (2005) · Circulation Research · doi:10.1161/01.res.0000159936.38601.22 · Cited by 250
The type III TGF-β receptor suppresses breast cancer progression
Dong, M., How, T., Kirkbride, K. C., Gordon, K. J., Lee, J. D., Hempel, N., Kelly, P., Moeller, B. J., Marks, J. R., & Blobe, G. C. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29293 · Cited by 246
Hamartomatous polyposis syndromes
Zbuk, K. M., & Eng, C. (2007) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0902 · Cited by 245
Monitoring Response to Anticancer Therapy by Targeting Microbubbles to Tumor Vasculature
Korpanty, G., Carbon, J. G., Grayburn, P. A., Fleming, J. B., & Brekken, R. A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1313 · Cited by 245
Reeves, R., Edberg, D. D., & Li, Y. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.2.575-594.2001 · Cited by 242
Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels
Fonsatti, E., Altomonte, M., Nicotra, M. R., Natali, P. G., & Maio, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206813 · Cited by 241
Stenvers, K. L., Tursky, M. L., Harder, K. W., Kountouri, N., Amatayakul-Chantler, S., Grail, D., Small, C., Weinberg, R. A., Sizeland, A. M., & Zhu, H.-J. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.12.4371-4385.2003 · Cited by 239
Molecular Classification of Patients With Unexplained Hamartomatous and Hyperplastic Polyposis
Sweet, K. (2005) · JAMA · doi:10.1001/jama.294.19.2465 · Cited by 234
LI, C., HAMPSON, I. N., HAMPSON, L., KUMAR, P., BERNABEU, C., & KUMAR, S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.1.55 · Cited by 230
Self-citationDRAGON, a Bone Morphogenetic Protein Co-receptor
Samad, T. A., Rebbapragada, A., Bell, E., Zhang, Y., Sidis, Y., Jeong, S.-J., Campagna, J. A., Perusini, S., Fabrizio, D. A., Schneyer, A. L., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410034200 · Cited by 228
Regulated expression on human macrophages of endoglin, an Arg‐Gly‐Asp‐containing surface antigen
Lastres, P., Bellon, T., Cabañas, C., Sanchez‐Madrid, F., Acevedo, A., Gougos, A., Letarte, M., & Bernabeu, C. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220216 · Cited by 227
Self-citationRole of Endoglin in Cellular Responses to Transforming Growth Factor-β
Letamendı́a, A., Lastres, P., Botella, L. M., Raab, U., Langa, C., Velasco, B., Attisano, L., & Bernabeu, C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.33011 · Cited by 224
Self-citationLatent TGFβ1 overexpression in keratinocytes results in a severe psoriasis‐like skin disorder
Li, A. G., Wang, D., Feng, X., & Wang, X. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600183 · Cited by 224
Guerrero-Esteo, M., Sánchez-Elsner, T., Letamendia, A., & Bernabéu, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111991200 · Cited by 219
Bellón, T., Corbi, A., Lastres, P., Calés, C., Cebrián, M., Vera, S., Cheifetz, S., Massague, J., Letarte, M., & Bernabéu, C. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230943 · Cited by 215
TP53 family members and human cancers
Bénard, J., Douc-Rasy, S., & Ahomadegbe, J.-C. (2003) · Human Mutation · doi:10.1002/humu.10172 · Cited by 206
Antagonists of activin signaling: mechanisms and potential biological applications
Harrison, C. A., Gray, P. C., Vale, W. W., & Robertson, D. M. (2005) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2005.01.003 · Cited by 205
Repulsive Guidance Molecule (RGMa), a DRAGON Homologue, Is a Bone Morphogenetic Protein Co-receptor
Babitt, J. L., Zhang, Y., Samad, T. A., Xia, Y., Tang, J., Campagna, J. A., Schneyer, A. L., Woolf, C. J., & Lin, H. Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503511200 · Cited by 204
Blanco, F. J., Santibanez, J. F., Guerrero‐Esteo, M., Langa, C., Vary, C. P. H., & Bernabeu, C. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20311 · Cited by 200
Self-citationGastric and duodenal polyps in Smad4 (Dpc4) knockout mice.
Takaku, K., Miyoshi, H., Matsunaga, A., Oshima, M., Sasaki, N., & Taketo, M. M. (1999) · PubMed · Cited by 198
A mouse model for hereditary hemorrhagic telangiectasia (HHT) type 2
Srinivasan, S. (2003) · Human Molecular Genetics · doi:10.1093/hmg/12.5.473 · Cited by 198
Miller, D. W., Graulich, W., Karges, B., Stahl, S., Ernst, M., Ramaswamy, A., Sedlacek, H.-H., M�ller, R., & Adamkiewicz, J. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990517)81:4<568::aid-ijc11>3.0.co;2-x · Cited by 196
Yamashita, H., Ichijo, H., Grimsby, S., Morén, A., ten Dijke, P., & Miyazono, K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42126-0 · Cited by 194
Bone Morphogenetic Proteins Signal through the Transforming Growth Factor-β Type III Receptor
Kirkbride, K. C., Townsend, T. A., Bruinsma, M. W., Barnett, J. V., & Blobe, G. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m704883200 · Cited by 193
A Novel Mechanism for Regulating Transforming Growth Factor β (TGF-β) Signaling
Blobe, G. C., Liu, X., Fang, S. J., How, T., & Lodish, H. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106831200 · Cited by 187
Gougos, A., St Jacques, S., Greaves, A., O'Connell, P. J., d'Apice, A. J. F., Bühring, H.-J., Bernabeu, C., van Mourik, J. A., & Letarte, M. (1992) · International Immunology · doi:10.1093/intimm/4.1.83 · Cited by 184
Self-citationEndoglin regulates nitric oxide‐dependent vasodilatation
Jerkic, M., Rivas‐Elena, J. V., Prieto, M., Carrón, R., Sanz‐Rodríguez, F., Pérez‐Barriocanal, F., Rodríguez‐Barbero, A., Bernabéu, C., & López‐Novoa, J. M. (2004) · The FASEB Journal · doi:10.1096/fj.03-0197fje · Cited by 184
A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues
Wang, J. M., Kumar, S., Pye, D., Krupinski, J., Hunter, R. D., & Van Agthoven, A. J. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910540303 · Cited by 183
Turley, R. S., Finger, E. C., Hempel, N., How, T., Fields, T. A., & Blobe, G. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3117 · Cited by 181
Friedl, W., Uhlhaas, S., Schulmann, K., Stolte, M., Loff, S., Back, W., Mangold, E., Stern, M., Knaebel, H.-P., Sutter, C., et al. (2002) · Human Genetics · doi:10.1007/s00439-002-0748-9 · Cited by 181
GermlineSMAD4 orBMPRIA mutations and phenotype of juvenile polyposis
Sayed, M. G., Ahmed, A. F., Ringold, J. R., Anderson, M. E., Bair, J. L., Mitros, F. A., Lynch, H. T., Tinley, S. T., Petersen, G. M., Giardiello, F. M., et al. (2002) · Annals of Surgical Oncology · doi:10.1007/bf02557528 · Cited by 180
Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer
Saad, R. S., Liu, Y. L., Nathan, G., Celebrezze, J., Medich, D., & Silverman, J. F. (2004) · Modern Pathology · doi:10.1038/modpathol.3800034 · Cited by 178
Botella, L. M., Sánchez-Elsner, T., Sanz-Rodriguez, F., Kojima, S., Shimada, J., Guerrero-Esteo, M., Cooreman, M. P., Ratziu, V., Langa, C., Vary, C. P. H., et al. (2002) · Blood · doi:10.1182/blood.v100.12.4001 · Cited by 175
Self-citationCD105 prevents apoptosis in hypoxic endothelial cells
Li, C., Issa, R., Kumar, P., Hampson, I. N., Lopez-Novoa, J. M., Bernabeu, C., & Kumar, S. (2003) · Journal of Cell Science · doi:10.1242/jcs.00470 · Cited by 174
Self-citationFonsatti, E., Vecchio, L. D., Altomonte, M., Sigalotti, L., Nicotra, M. R., Coral, S., Natali, P. G., & Maio, M. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.1095 · Cited by 173
Inducible expression of human endoglin during inflammation and wound healing in vivo
Torsney, E., Charlton, R., Parums, D. V., Collis, M. G., & Arthur, H. M. (2002) · Inflammation Research · doi:10.1007/pl00012413 · Cited by 171
Seon, B. K., Matsuno, F., Haruta, Y., Kondo, M., & Barcos, M. P. (1997) · PubMed · Cited by 166
Sanz-Rodriguez, F., Guerrero-Esteo, M., Botella, L.-M., Banville, D., Vary, C. P. H., & Bernabéu, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400843200 · Cited by 164
Esparza-López, J., Montiel, J. L., Vilchis-Landeros, M. M., Okadome, T., Miyazono, K., & López-Casillas, F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008866200 · Cited by 164
Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer
Fonsatti, E., & Maio, M. (2004) · Journal of Translational Medicine · doi:10.1186/1479-5876-2-18 · Cited by 164
Receptors for the TGF-β superfamily: multiple polypeptides and serine/threonine kinases
Lin, H. Y., & Lodish, H. F. (1993) · Trends in Cell Biology · doi:10.1016/0962-8924(93)90195-7 · Cited by 163
Identification of CD109 as part of the TGF‐β receptor system in human keratinocytes
Finnson, K. W., Tam, B. Y. Y., Liu, K., Marcoux, A., Lepage, P., Roy, S., Bizet, A. A., & Philip, A. (2006) · The FASEB Journal · doi:10.1096/fj.05-5229fje · Cited by 163
Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival
Ragnarsson, G., Eiriksdottir, G., Johannsdottir, J. T., Jonasson, J. G., Egilsson, V, & Ingvarsson, S. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690234 · Cited by 159
Carvalho, R. L. C., Jonker, L., Goumans, M.-J., Larsson, J., Bouwman, P., Karlsson, S., Dijke, P. T., Arthur, H. M., & Mummery, C. L. (2004) · Development · doi:10.1242/dev.01529 · Cited by 159
Escaping from the TGF anti-proliferative control
Seoane, J. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl068 · Cited by 153
Takahashi, N., Haba, A., Matsuno, F., & Seon, B. K. (2001) · PubMed · Cited by 150
Betaglycan Inhibits TGF-β Signaling by Preventing Type I-Type II Receptor Complex Formation
Eickelberg, O., Reiß, M., Kashgarian, M. J., & Wells, R. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105110200 · Cited by 149
Endoglin Has a Crucial Role in Blood Cell–Mediated Vascular Repair
Laake, L. W. V., van den Driesche, S., Post, S., Feijen, A., Jansen, M. A., Driessens, M. H. E., Mager, J. J., Snijder, R. J., Westermann, C. J. J., Doevendans, P. A., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.639161 · Cited by 147
Multistep skin cancer in mice as a model to study the evolution of cancer cells
Kemp, C. J. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.06.003 · Cited by 146
Matsuno, F., Haruta, Y., Kondo, M., Tsai, H., Barcos, M. P., & Seon, B. K. (1999) · PubMed · Cited by 144
A delicate balance: TGF‐β and the tumor microenvironment
Stover, D. G., Bierie, B., & Moses, H. L. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21149 · Cited by 142
Coronary Vessel Development Is Dependent on the Type III Transforming Growth Factor β Receptor
Compton, L. A., Potash, D. A., Brown, C. B., & Barnett, J. V. (2007) · Circulation Research · doi:10.1161/circresaha.107.152082 · Cited by 141
Antitumor activity of a recombinant soluble betaglycan in human breast cancer xenograft.
Bandyopadhyay, A. M., López‐Casillas, F., Malik, S. N., Montiel-Hernández, J. L., Mendoza, V., Yang, J., & Sun, L. (2002) · PubMed · Cited by 140
Blobe, G. C., Schiemann, W. P., Pépin, M.-C., Beauchemin, M., Moustakas, A., Lodish, H. F., & O'Connor‐McCourt, M. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100188200 · Cited by 140
Novel biochemical pathways of endoglin in vascular cell physiology
Bernabéu, C., Conley, B. A., & Vary, C. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21594 · Cited by 135
Fonsatti, E., Jekunen, A. P., Kairemo, K., et al. (2000) · PubMed · Cited by 135
Tumor suppressor activity of RUNX3
Bae, S., & Choi, J.-K. (2004) · Oncogene · doi:10.1038/sj.onc.1207286 · Cited by 134
Sankar, S., Mahooti-Brooks, N., McCarthy, T. L., & Madri, J. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.13567 · Cited by 131
Identification of a global gene expression signature of B-chronic lymphocytic leukemia.
Jelinek, D. F., Tschumper, R. C., Stolovitzky, G. A., Iturria, S. J., Tu, Y., Lepre, J., Shah, N. H., & Kay, N. E. (2003) · PubMed · Cited by 131
Endoglin Controls Cell Migration and Composition of Focal Adhesions
Conley, B. A., Koleva, R., Smith, J. D., Kacer, D., Zhang, D., Bernabéu, C., & Vary, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312561200 · Cited by 130
El-Gohary, Y., Silverman, J. F., Olson, P., Liu, Y. L., Cohen, J., Miller, R., & Saad, R. S. (2007) · American Journal of Clinical Pathology · doi:10.1309/x6nxye57dlue2nq8 · Cited by 129
Machado, R. D. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg365 · Cited by 129
Breast Carcinoma: Comparative Study of Tummor Vasculature Using Two Endothelial Cell Markers
Wang, J. M., Kumar, S. S., Pye, D. A., et al. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.5.386 · Cited by 126
Takahashi, N. K., Kawanishi‐Tabata, R., Haba, A., Tabata, M., Haruta, Y., Tsai, H., & Seon, B. K. (2001) · PubMed · Cited by 124
Pece-Barbara, N., Vera, S., Kathirkamathamby, K., Liebner, S., Guglielmo, G. M. D., Dejana, E., Wrana, J. L., & Letarte, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503471200 · Cited by 124
Reduced angiogenic responses in adult endoglin heterozygous mice
Jerkić, M., Rodríguez‐Barbero, A., Prieto, M., Toporsian, M., Pericacho, M., Rivas‐Elena, J. V., Obreo, J., Wang, A., Pérez‐Barriocanal, F., Arévalo, M., et al. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.11.020 · Cited by 124
Loss of Betaglycan Expression in Ovarian Cancer: Role in Motility and Invasion
Hempel, N., How, T., Dong, M., Murphy, S. K., Fields, T. A., & Blobe, G. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0035 · Cited by 124
Li, C., Gardy, R., Seon, B. K., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600874 · Cited by 120
Santibanez, J. F., Letamendía, A., Pérez‐Barriocanal, F., Silvestri, C., Saura, M., Vary, C., López-Novoa, J. M., Attisano, L., & Bernabéu, C. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20878 · Cited by 117
The p38 MAPK stress pathway as a tumor suppressor or more?
Loesch, M., & Chen, G. (2008) · Frontiers in bioscience · doi:10.2741/2951 · Cited by 117
Nettelbeck, D. M., Miller, D. W., Jérôme, V., Zuzarte, M., Watkins, S. J., Hawkins, R. E., Müller, R., & Kontermann, R. E. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0342 · Cited by 115
Bandyopadhyay, A. M., Zhu, Y., Cibull, M. L., Bao, L., Chen, C., & Sun, L. (1999) · PubMed · Cited by 115
Imaging of tumour neovasculature by targeting the TGF-β binding receptor endoglin
Bredow, S., Lewin, M., Hofmann, B., et al. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00335-4 · Cited by 113
TβRIII suppresses non-small cell lung cancer invasiveness and tumorigenicity
Finger, E. C., Turley, R. S., Dong, M., How, T., Fields, T. A., & Blobe, G. C. (2008) · Carcinogenesis · doi:10.1093/carcin/bgm289 · Cited by 112
Rı́us, C., Smith, J. D., Almendro, N., Langa, C., Botella, L. M., Marchuk, D. A., Vary, C., & Bernabéu, C. (1998) · Blood · doi:10.1182/blood.v92.12.4677 · Cited by 111
Inhibition of TGFβ signaling in cancer therapy
Arteaga, C. L. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2005.12.009 · Cited by 111
Leask, A., Abraham, D., Finlay, D. R., Holmes, A. M., Pennington, D. W., Shiwen, X., Chen, Y., Venstrom, K., Dou, X.-W., Ponticos, M., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10333 · Cited by 108
Transforming growth factor-β (TGF-β) receptor proteoglycan
Cheifetz, S., & Massagué, J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)80169-7 · Cited by 106
Endoglin Structure and Function
Koleva, R., Conley, B. A., Romero, D., Riley, K. S., Marto, J. A., Lux, A., & Vary, C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601288200 · Cited by 105
Liu, Y., Jovanovic, B. D., Pins, M., Lee, C., & Bergan, R. C. (2002) · Oncogene · doi:10.1038/sj.onc.1206117 · Cited by 105
Deletion and altered regulation of p16INK4a and p15INK4b in undifferentiated mouse skin tumors.
Linardopoulos, S., Street, A. J., Quelle, D. E., Parry, D., Peters, G. G., Sherr, C. J., & Balmain, A. (1995) · PubMed · Cited by 105
Pruneri, G., Ponzoni, M., Ferreri, A. J. M., Decarli, N., Tresoldi, M., Raggi, F., Baldessari, C., Freschi, M., Baldini, L., Goldaniga, M. C., et al. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03654.x · Cited by 104
Llorca, Ó., Trujillo, A., Blanco, F. J., & Bernabéu, C. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.10.015 · Cited by 104
Endoglin Differentially Modulates Antagonistic Transforming Growth Factor-β1 and BMP-7 Signaling
Scherner, O., Meurer, S. K., Tihaa, L., Gressner, A. M., & Weiskirchen, R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611062200 · Cited by 102
Endoglin overexpression modulates cellular morphology, migration, and adhesion of mouse fibroblasts
Guerrero-Esteo, M., Lastres, P., Letamendía, A., Pérez-Álvarez, M. J., Langa, C., López, L. A., Fabra, À., García-Pardo, A., Vera, S., Letarte, M., et al. (1999) · European Journal of Cell Biology · doi:10.1016/s0171-9335(99)80046-6 · Cited by 101
Copland, J. A., Luxon, B. A., Ajani, L., Maity, T., Campagnaro, E. L., Guo, H., LeGrand, S. N., Tamboli, P., & Wood, C. G. (2003) · Oncogene · doi:10.1038/sj.onc.1206835 · Cited by 101
Blanco, F. J., Grande, M. T., Langa, C., Oujo, B., Velasco, S., Rodríguez‐Barbero, A., Pérez-Gómez, E., Quintanilla, M., López-Novoa, J. M., & Bernabéu, C. (2008) · Circulation Research · doi:10.1161/circresaha.108.176552 · Cited by 101
Self-citationRecent advances in cancer research: mouse models of tumorigenesis
Herzig, M., & Christofori, G. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00039-2 · Cited by 100
The role of transforming growth factor Β in glioma progression
Jennings, M. T., & Pietenpol, J. A. (1998) · Journal of Neuro-Oncology · doi:10.1023/a:1005863419880 · Cited by 99
Characterization of murine S-endoglin isoform and its effects on tumor development
Pérez-Gómez, E., Eleno, N., López-Novoa, J. M., Ramirez, J. R., Velasco, B., Letarte, M., Bernabéu, C., & Quintanilla, M. (2005) · Oncogene · doi:10.1038/sj.onc.1208644 · Cited by 97
Self-citationAkagi, K., Ikeda, Y., Sumiyoshi, Y., et al. (2002) · Surgery · doi:10.1067/msy.2002.119361 · Cited by 95
Liu, X. Z., Alexander, V., Vijayachandra, K., Bhogte, E., Diamond, I., & Glick, A. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161016098 · Cited by 93
Endoglin expression on human microvascular endothelial cells
Wong, S. H., Hamel, L., Chevalier, S., & Philip, A. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01621.x · Cited by 92
Lee, N. Y., & Blobe, G. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700176200 · Cited by 90
Vilchis‐Landeros, M. M., Montiel-Hernández, J. L., Mendoza, V., Mendoza‐Hernández, G., & López‐Casillas, F. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3550215 · Cited by 89
Endoglin expression as a measure of microvessel density in cervical cancer
Brewer, C. A. (2000) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(00)00864-4 · Cited by 85
Endoglin (CD105) Expression in Endometrial Carcinoma
Saad, R. S., Jasnosz, K. M., Tung, M. Y., & Silverman, J. F. (2003) · International Journal of Gynecological Pathology · doi:10.1097/01.pgp.0000070852.25718.37 · Cited by 85
Cloning and expression of a cDNA encoding mouse endoglin, an endothelial cell TGF-β ligand
Ge, A. Z., & Butcher, E. C. (1994) · Gene · doi:10.1016/0378-1119(94)90808-7 · Cited by 84
Morén, A., Ichijo, H., & Miyazono, K. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91566-9 · Cited by 84
Smad3 Knockout Mice Exhibit a Resistance to Skin Chemical Carcinogenesis
Li, A. G., Lu, S., Zhang, M., Deng, C., & Wang, X. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1331 · Cited by 82
Endoglin expression in metastatic breast cancer cells enhances their invasive phenotype
Oxmann, D., Held‐Feindt, J., Stark, A. M., Hattermann, K., Yoneda, T., & Mentlein, R. (2008) · Oncogene · doi:10.1038/sj.onc.1211025 · Cited by 81
Bandyopadhyay, A. M., Wang, L., López‐Casillas, F., Mendoza, V., Yeh, I., & Sun, L. (2004) · The Prostate · doi:10.1002/pros.20166 · Cited by 78
Expression of endoglin in human mesangial cells: modulation of extracellular matrix synthesis
Díez-Marqués, L., Ortega-Velázquez, R., Langa, C., Rodríguez‐Barbero, A., López-Novoa, J. M., Lamas, S., & Bernabéu, C. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00051-0 · Cited by 78
Botella, L. M., Sánchez-Elsner, T., Rı́us, C., Corbí, A. L., & Bernabéu, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011611200 · Cited by 78
Reduced Tumor Growth and Angiogenesis in Endoglin-Haploinsufficient Mice
Düwel, A., Eleno, N., Jerkić, M., Arévalo, M. A., Bolaños, J. P., Bernabéu, C., & López-Novoa, J. M. (2006) · Tumor Biology · doi:10.1159/000097040 · Cited by 77
Phosphorylation of the human-transforming-growth-factor-β-binding protein endoglin
Lastres, P., Martín-Pérez, J., Langa, C., & Bernabéu, C. (1994) · Biochemical Journal · doi:10.1042/bj3010765 · Cited by 76
Genetic conditions associated with intestinal juvenile polyps
Merg, A., & Howe, J. R. (2004) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.30020 · Cited by 76
Quintanilla, M., Ramirez, J. R., Pérez-Gómez, E., Romero, D., Velasco, B., Letarte, M., López-Novoa, J. M., & Bernabéu, C. (2003) · Oncogene · doi:10.1038/sj.onc.1206841 · Cited by 73
Self-citationDisturbed angiogenesis in systemic sclerosis: high levels of soluble endoglin
Wipff, J., Avouac, J., Borderie, D., Zerkak, D., Lemaréchal, H., Kahan, A., Boileau, C., & Allanore, Y. (2008) · Rheumatology · doi:10.1093/rheumatology/ken100 · Cited by 73
Loss of Betaglycan Contributes to the Malignant Properties of Human Granulosa Tumor Cells
Bilandzic, M., Chu, S., Farnworth, P. G., Harrison, C. A., Nicholls, P. K., Wang, Y., Escalona, R. M., Fuller, P. J., Findlay, J. K., & Stenvers, K. L. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0300 · Cited by 70
Endoglin is required for hemangioblast and early hematopoietic development
Perlingeiro, R. C. R. (2007) · Development · doi:10.1242/dev.002907 · Cited by 70
Mouse models for multistep tumorigenesis.
Wu, X.-M., & Pandolfi, P. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02127-4 · Cited by 70
Endoglin-Mediated Vascular Remodeling: Mechanisms Underlying Hereditary Hemorrhagic Telangiectasia
Lebrin, F., & Mummery, C. L. (2008) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2007.11.003 · Cited by 69
Bristow, R. E., Baldwin, R. L., Yamada, S., Korc, M., & Karlan, B. Y. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990201)85:3<658::aid-cncr16>3.0.co;2-m · Cited by 68
Völkel, T., Hölig, P., Merdan, T., et al. (2004) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2004.03.007 · Cited by 67
Endoglin (CD105) as a prognostic factor in head and neck squamous cell carcinoma
Kyzas, P., Agnantis, N. J., & Stefanou, D. (2006) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-006-0195-4 · Cited by 66
Endoglin (CD105) is a target for an oral DNA vaccine against breast cancer
Lee, S., Mizutani, N., Mizutani, M., Luo, Y., Zhou, H., Kaplan, C., Kim, S.-W., Xiang, R., & Reisfeld, R. A. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0155-5 · Cited by 66
Lux, A. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.5.745 · Cited by 64
Finger, E. C., Lee, N. Y., You, H. J., & Blobe, G. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804741200 · Cited by 62
She, X., Matsuno, F., Harada, N., Tsai, H., & Seon, B. K. (2003) · International Journal of Cancer · doi:10.1002/ijc.11551 · Cited by 62
Endoglin (CD105) as a urinary and serum marker of prostate cancer
Fujita, K., Ewing, C. M., Chan, D. Y. S., Mangold, L. A., Partin, A. W., Isaacs, W. B., & Pavlovich, C. P. (2008) · International Journal of Cancer · doi:10.1002/ijc.24007 · Cited by 62
TGFBR3 loss and consequences in prostate cancer
Sharifi, N., Hurt, E. M., Kawasaki, B. T., & Farrar, W. L. (2006) · The Prostate · doi:10.1002/pros.20526 · Cited by 62
Inhibin Resistance Is Associated with Aggressive Tumorigenicity of Ovarian Cancer Cells
Steller, M. D., Shaw, T. J., Vanderhyden, B. C., & Éthier, J.-F. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.50.3.1 · Cited by 62
Brewer, C. A., Blessing, J. A., Nagourney, R. A., Morgan, M. A., & Hanjani, P. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.03.018 · Cited by 61
Role of TGFβ in skin inflammation and carcinogenesis
Li, A. G., Lu, S., Han, G., Hoot, K. E., & Wang, X. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20229 · Cited by 60
High expressions of CD105 and VEGF in early oral cancer predict potential cervical metastasis
Chien, C., Su, C., Hwang, C., et al. (2006) · Journal of Surgical Oncology · doi:10.1002/jso.20546 · Cited by 60
Cited by
Wu, M., Chen, G., & Li, Y.-P. (2016) · Bone Research · doi:10.1038/boneres.2016.9 · Cited by 1,553
Proteoglycan form and function: A comprehensive nomenclature of proteoglycans
Iozzo, R. V., & Schaefer, L. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.02.003 · Cited by 1,263
The TGFbeta Superfamily Signaling Pathway
Weiss, A., & Attisano, L. (2013) · WIREs Developmental Biology · doi:10.1002/wdev.86 · Cited by 561
How Tolerogenic Dendritic Cells Induce Regulatory T Cells
Maldonado, R. A., & von Andrian, U. H. (2010) · Advances in Immunology · doi:10.1016/b978-0-12-380995-7.00004-5 · Cited by 541
Angiogenesis Inhibitors: Current Strategies and Future Prospects
Cook, K. M., & Figg, W. D. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20075 · Cited by 474
Metadata
- Authors
- Bernabeu, C., Lopez-Novoa, J. M., & Quintanilla, M.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Published
- 2009-10
- Volume
- 1792
- Issue
- 10
- Pages
- 954-973
- ISSN
- 0925-4439 (ISSN-L)
- OpenAlex
- W2110167662
- Cited by
- 254
- References
- 237
- FWCI
- 9.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.